Daily Stock Analysis, BGNE, BeiGene Ltd, priceseries

BeiGene Ltd. Daily Stock Analysis
Stock Information
Open
169.80
Close
170.10
High
171.37
Low
166.48
Previous Close
168.29
Daily Price Gain
1.81
YTD High
220.10
YTD High Date
Jun 8, 2018
YTD Low
95.34
YTD Low Date
Jan 17, 2018
YTD Price Change
69.29
YTD Gain
68.73%
52 Week High
220.10
52 Week High Date
Jun 8, 2018
52 Week Low
43.08
52 Week Low Date
Jun 23, 2017
52 Week Price Change
125.25
52 Week Gain
279.26%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 23. 2017
32.39
Feb 7. 2017
34.41
11 Trading Days
6.22%
Link
LONG
Feb 10. 2017
36.00
Feb 23. 2017
37.84
8 Trading Days
5.11%
Link
LONG
Apr 24. 2017
37.61
May 4. 2017
39.82
8 Trading Days
5.88%
Link
LONG
Jun 16. 2017
41.56
Jul 24. 2017
72.26
25 Trading Days
73.86%
Link
LONG
Sep 13. 2017
75.61
Oct 12. 2017
103.49
21 Trading Days
36.87%
Link
LONG
Jan 17. 2018
102.63
Feb 6. 2018
125.11
14 Trading Days
21.91%
Link
LONG
Feb 14. 2018
129.24
Feb 28. 2018
145.52
9 Trading Days
12.60%
Link
LONG
May 29. 2018
192.36
Jun 11. 2018
204.36
9 Trading Days
6.24%
Link
Company Information
Stock Symbol
BGNE
Exchange
NasdaqGS
Company URL
http://www.beigene.com
Company Phone
13459494123
CEO
John V. Oyler
Headquarters
-
Business Address
C/O MOURANT OZANNES CORPORATE SERVICES, 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, CAYMAN ISLANDS KY1-1108
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001651308
About

BeiGene Ltd. operates as a holding company, which engages in the research and development of biopharmaceutical products. It develops immuno-oncology drugs for cancer treatment. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Description

Chinese biotech developing cancer therapies for China and global markets.